Patents by Inventor Rico Laage

Rico Laage has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8349619
    Abstract: The invention relates to various methods of detecting and analyzing protein interactions in a cell, which methods involve the appearance of a specific protein interaction being converted to a permanent detection signal by means of providing, in a manner dependent on said protein interaction, a recombinase activity or protease activity.
    Type: Grant
    Filed: May 1, 2009
    Date of Patent: January 8, 2013
    Assignee: Sygnis Bioscience GmbH & Co. KG
    Inventors: Moritz Rossner, Rico Laage, Klaus-Armin Nave, Sylvia Gruenewald
  • Publication number: 20100284926
    Abstract: The invention relates to the use of G-CSF for the treatment of cerebral stroke, particularly cerebral stroke with a large baseline infarct volume. Administration of G-CSF at a total dose of 30 to 180 ?g per kg body weight over a treatment period of about 3 days is suitable for the treatment of stroke. Treatment in accordance with the invention with a total dose of 80 to 150 ?g per kg body weight is preferred.
    Type: Application
    Filed: September 12, 2008
    Publication date: November 11, 2010
    Applicant: Sygnis Bioscience GmbH & Co. KG
    Inventors: Armin Schneider, Rico Laage, Gerhard Vogt, Winfried Koch
  • Publication number: 20100179130
    Abstract: The present invention relates to the use of piperine and derivatives thereof for the preparation of a pharmaceutical composition for treating and/or preventing a neuronal condition where there is a need of neuroprotection and/or neuroregeneration. The invention furthermore relates to the use of piperine and derivatives thereof for the in vitro differentiation of neural stem cells and the use of such pre-treated cells for stem cell therapy von neurological conditions.
    Type: Application
    Filed: July 3, 2008
    Publication date: July 15, 2010
    Applicant: SYNGIS Bioscience GmbH & Co. KG
    Inventors: Armin Schneider, Anja Moraru, Carola Krüger, Rico Laage, Claudia Pitzer
  • Publication number: 20090298089
    Abstract: The invention relates to various methods of detecting and analyzing protein interactions in a cell, which methods involve the appearance of a specific protein interaction being converted to a permanent detection signal by means of providing, in a manner dependent on said protein interaction, a recombinase activity or protease activity.
    Type: Application
    Filed: May 1, 2009
    Publication date: December 3, 2009
    Inventors: Moritz Rossner, Rico Laage, Klaus-Armin Nave, Sylvia Gruenewald
  • Patent number: 7585635
    Abstract: Described are various methods of detecting and analyzing protein interactions in a cell. The specific protein interaction is detected by a permanent signal generated by a recombinase activity or protease activity that depends on the protein interaction.
    Type: Grant
    Filed: March 13, 2003
    Date of Patent: September 8, 2009
    Assignee: Sygnis Bioscience GmbH & Co. KG
    Inventors: Moritz Rossner, Rico Laage, Klaus-Armin Nave, Sylvia Gruenewald
  • Publication number: 20050084864
    Abstract: The invention relates to a method of detecting and analyzing protein interactions in a cell, which comprises the steps: d) provision of the activity of at least one enzyme from the group consisting of recombinases and proteases in the cell as a result of a protein interaction, e) continual generation of an active reporter protein in the cell in question as a result of the enzymic activity of step a) for a period of time which exceeds the duration of the protein interaction of step a), f) generation of a detection signal by the reporter proteins generated in b). The invention furthermore relates to reverse embodiments of the method above of detecting and analyzing protein interactions in a cell, with, as a result of the induced dissociation of a defined interaction between proteins, the activity of at least one enzyme from the group consisting of recombinases and proteases being provided in the cell and converted to a permanent detection signal of said cell.
    Type: Application
    Filed: March 13, 2003
    Publication date: April 21, 2005
    Applicant: AXARON BIOSCIENCE AG
    Inventors: Moritz Rossner, Rico Laage, Klaus-Armin Nave, Sylvia Gruenewald